RadNet, Inc.
RDNT
Classifica tra le azioni
#3221
RadNet, Inc. operates as a prominent healthcare services company specializing... RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
Prezzo delle azioni
$70.34
Capitalizzazione di mercato
$5.54B
Variazione (1 giorno)
1.54%
Variazione (1 anno)
-10.33%
Paese
US
Scambia RadNet, Inc. (RDNT)
Categoria
Healthcare
Ricavi di RadNet, Inc. (RDNT)
Ricavi nel Jun 2026 TTM: $2.27B
Secondo gli ultimi rapporti finanziari di RadNet, Inc., i ricavi attuali dell'azienda (TTM) sono pari a $2.27B. Nel 2023, l'azienda ha registrato ricavi di $1.62B un aumento rispetto a i ricavi dell'anno 2022, che erano pari a $1.43B. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per RadNet, Inc. da 2000 a 2026
Ricavi alla fine di ogni anno
| Anno | Ricavi | Cambia |
|---|---|---|
| 2026 (TTM) | $2.27B | 24.01% |
| 2024 | $1.83B | 13.18% |
| 2023 | $1.62B | 13.05% |
| 2022 | $1.43B | 8.74% |
| 2021 | $1.32B | 22.69% |
| 2020 | $1.07B | -7.13% |
| 2019 | $1.15B | 18.36% |
| 2018 | $975.15M | 5.74% |
| 2017 | $922.19M | 4.26% |
| 2016 | $884.54M | 9.25% |
| 2015 | $809.63M | 12.83% |
| 2014 | $717.57M | 2.07% |
| 2013 | $702.99M | 8.63% |
| 2012 | $647.15M | 4.41% |
| 2011 | $619.80M | 12.99% |
| 2010 | $548.54M | 4.61% |
| 2009 | $524.37M | 4.43% |
| 2008 | $502.12M | 18.01% |
| 2007 | $425.47M | 164.26% |
| 2006 | $161.01M | 10.60% |
| 2005 | $145.57M | 6.04% |
| 2004 | $137.28M | -2.13% |
| 2003 | $140.26M | 0.70% |
| 2002 | $139.28M | 24.54% |
| 2001 | $111.84M | 27.14% |
| 2000 | $87.96M | 0.00% |
Ricavi di aziende simili o concorrenti
| Azienda | Ricavi | Differenza nei ricavi | Il paese |
|---|---|---|---|
| $46.34B | 1,942.19% |
US
|
|
| $25.11B | 1,006.56% |
US
|
|
| $2.71B | 19.31% |
US
|
|
| - | - |
CN
|
|
| $7.37B | 224.91% |
US
|
